These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11213897)
1. Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes. Hsueh WA; Jackson S; Law RE Diabetes Care; 2001 Feb; 24(2):392-7. PubMed ID: 11213897 [TBL] [Abstract][Full Text] [Related]
2. PPARgamma and atherosclerosis: effects on cell growth and movement. Hsueh WA; Law RE Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1891-5. PubMed ID: 11742860 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells. Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480 [TBL] [Abstract][Full Text] [Related]
4. Vascular protective effects by activation of nuclear receptor PPARgamma. Wakino S; Law RE; Hsueh WA J Diabetes Complications; 2002; 16(1):46-9. PubMed ID: 11872366 [TBL] [Abstract][Full Text] [Related]
5. Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Law RE; Goetze S; Xi XP; Jackson S; Kawano Y; Demer L; Fishbein MC; Meehan WP; Hsueh WA Circulation; 2000 Mar; 101(11):1311-8. PubMed ID: 10725292 [TBL] [Abstract][Full Text] [Related]
6. Metabolic and additional vascular effects of thiazolidinediones. Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315 [TBL] [Abstract][Full Text] [Related]
7. Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma. Itoh H; Doi K; Tanaka T; Fukunaga Y; Hosoda K; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Nakao K Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):558-60. PubMed ID: 10405788 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Sugawara A; Takeuchi K; Uruno A; Ikeda Y; Arima S; Kudo M; Sato K; Taniyama Y; Ito S Endocrinology; 2001 Jul; 142(7):3125-34. PubMed ID: 11416035 [TBL] [Abstract][Full Text] [Related]
12. PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR Diabetes; 1997 Jul; 46(7):1230-4. PubMed ID: 9200661 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors and the cardiovascular system. Chen YE; Fu M; Zhang J; Zhu X; Lin Y; Akinbami MA; Song Q Vitam Horm; 2003; 66():157-88. PubMed ID: 12852255 [TBL] [Abstract][Full Text] [Related]
14. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression. Brunmair B; Gras F; Neschen S; Roden M; Wagner L; Waldhäusl W; Fürnsinn C Diabetes; 2001 Oct; 50(10):2309-15. PubMed ID: 11574413 [TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. Schiffrin EL; Amiri F; Benkirane K; Iglarz M; Diep QN Hypertension; 2003 Oct; 42(4):664-8. PubMed ID: 12874098 [TBL] [Abstract][Full Text] [Related]
17. Novel insulin sensitizers: pharmacogenomic aspects. Otto C; Lehrke M; Göke B Pharmacogenomics; 2002 Jan; 3(1):99-116. PubMed ID: 11966407 [TBL] [Abstract][Full Text] [Related]
18. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis. Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone. Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Rangwala SM; Lazar MA Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]